Quoin Pharmaceuticals, Ltd.
QNRX$29.32B
Large CapNASDAQPharmaceutical Preparations🇺🇸North AmericaKFAR SABA3 employees
Drugs in Pipeline
2
Phase 3 Programs
2
Upcoming Catalysts
1
Next Catalyst
Jul 30, 2026
20wMarket Overview
Stock performance and key metrics
QNRX News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
QRX003, 4% Lotion | Phase 3 | Netherton Syndrome | - | - |
QRX003-2% Lotion | Phase 3 | Netherton Syndrome | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply